Schizophrenia

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Scientific Council member Anil K. Malhotra, M.D.,  professor of psychiatry at Hofstra North Shore-LIJ School of Medicine and also serves in the Division of Psychiatry Research in the Zucker Hillside Hospital campus of The Feinstein Institute for Medical Research, both in New York, Expert on mental illness
Anil K. Malhotra, M.D.
June 19, 2012
‘Second’ generation antipsychotic medications are known as atypical antipsychotic drugs (AAPD). Among them are clozapine and olanzapine (Clozaril® and Zyprexa...
Janet Susin, president of the Queens/Nassau chapter of the National Alliance on Mental Illness
Janet Susin
June 08, 2012
From The Quarterly, Spring 2012 Like many donors to the Brain & Behavior Research Foundation, Janet and Myron Susin of Long Island, New York, have a...
Chiara Nosarti  Ph.D., Institute of Psychiatry, Kings College London
Chiara Nosarti Ph.D.
June 04, 2012
One of the largest studies to investigate birth complications and later mental health has found that premature birth (less than 32 weeks gestation) constitutes...
Alexander Niculescu, III, M.D., Ph.D., scizophrenia
Alexander Niculescu, III, M.D., Ph.D.
May 17, 2012
NARSAD Young Investigator Grantee, Alexander Niculescu, III, M.D., Ph.D. has led a team of scientists at the Indiana University School of Medicine in...
Guo-li Ming, M.D., Ph.D.
Guo-li Ming, M.D., Ph.D.
March 29, 2012
In findings recently published in Cell, 2010 NARSAD Independent Investigator Grantee, Guo-li Ming, M.D., Ph.D., and colleagues at Johns Hopkins University...

Pages

Subscribe to